NCT00418093: Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma |
|
|
| Terminated | 2 | 19 | US | Gemcitabine, Oxaliplatin, Bevacizumab | Dana-Farber Cancer Institute, Massachusetts General Hospital, Brigham and Women's Hospital, Eli Lilly and Company, Sanofi-Synthelabo, Genentech, Inc. | Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | 01/11 | 10/11 | | |
